178 related articles for article (PubMed ID: 10580183)
1. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
Shoji T; Nishizawa Y; Fukumoto M; Shimamura K; Kimura J; Kanda H; Emoto M; Kawagishi T; Morii H
Atherosclerosis; 2000 Jan; 148(1):171-7. PubMed ID: 10580183
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population.
Fukumoto M; Shoji T; Emoto M; Kawagishi T; Okuno Y; Nishizawa Y
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):703-7. PubMed ID: 10712394
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
4. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
[TBL] [Abstract][Full Text] [Related]
5. Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males.
Barud W; Palusiński R; Bełtowski J; Wójcicka G
Atherosclerosis; 2002 Oct; 164(2):283-8. PubMed ID: 12204799
[TBL] [Abstract][Full Text] [Related]
6. The association between oxidized low-density lipoprotein antibodies and hematological diseases.
Li H; Li DQ; Li XX; Wang LQ
Lipids Health Dis; 2016 Nov; 15(1):190. PubMed ID: 27825356
[TBL] [Abstract][Full Text] [Related]
7. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
8. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
[TBL] [Abstract][Full Text] [Related]
11. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
12. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
[TBL] [Abstract][Full Text] [Related]
13. [Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].
Itabe H
Yakugaku Zasshi; 2002 Oct; 122(10):745-53. PubMed ID: 12400156
[TBL] [Abstract][Full Text] [Related]
14. Oxidized low-density lipoproteins and their antibodies: relationships with the reverse cholesterol transport and carotid atherosclerosis in adults without cardiovascular diseases.
Ferreira PF; Zago VH; D'Alexandri FL; Panzoldo NB; Gidlund MA; Nakamura RT; Schreiber R; Parra ES; Santiago FD; Nakandakare ER; Quintão EC; de Faria EC
Clin Chim Acta; 2012 Oct; 413(19-20):1472-8. PubMed ID: 22659061
[TBL] [Abstract][Full Text] [Related]
15. Association of apolipoprotein A phenotypes and oxidized low-density lipoprotein immune complexes in children.
Islam S; Gutin B; Treiber F; Hobbs G; Kamboh I; Lopes-Virella M
Arch Pediatr Adolesc Med; 1999 Jan; 153(1):57-62. PubMed ID: 9895000
[TBL] [Abstract][Full Text] [Related]
16. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
17. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
Sämpi M; Ukkola O; Päivänsalo M; Kesäniemi YA; Binder CJ; Hörkkö S
J Am Coll Cardiol; 2008 Oct; 52(17):1370-8. PubMed ID: 18940525
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
19. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
Tsimikas S; Brilakis ES; Lennon RJ; Miller ER; Witztum JL; McConnell JP; Kornman KS; Berger PB
J Lipid Res; 2007 Feb; 48(2):425-33. PubMed ID: 17093289
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]